SCHEMBL26341684

SCHEMBL26341684

O=C(NNC(=O)c1cc(-c2ccc(Cl)cc2)nn1-c1ccccc1)c1ccccn1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 4/20 0.62
▸ LMNA P02545 4/20 0.62
▸ SMN1; SMN2 Q16637 3/20 0.62
▸ CXCR5 P32302 1/20 0.62
▸ APLNR P35414 1/20 0.62
▸ CCR6 P51684 1/20 0.62
▸ GRM5 P41594 3/20 0.61
▸ TLR7 Q9NYK1 3/20 0.54
▸ MAPT P10636 2/20 0.53
▸ KMT2A Q03164 4/20 0.52
▸ HPGD P15428 1/20 0.52
▸ L3MBTL1 Q9Y468 1/20 0.52
▸ PTPN1 P18031 1/20 0.51
▸ POLB P06746 1/20 0.50
▸ HTT P42858 1/20 0.50
▸ KDM4E B2RXH2 3/20 0.49
▸ MEN1 O00255 3/20 0.49
▸ NPC1 O15118 1/20 0.49
▸ RAB9A P51151 1/20 0.49
▸ MALT1 Q9UDY8 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26341419 0.82 ALDH1A1 (0.68) ALDH1A1LMNASMN1; SMN2CXCR5APLNR
SCHEMBL26342427 0.81 LMNA (0.72) ALDH1A1LMNASMN1; SMN2CXCR5APLNR
SCHEMBL26342422 0.79 MEN1 (0.62) ALDH1A1LMNASMN1; SMN2CXCR5APLNR
SCHEMBL26341512 0.77 LMNA (1.00) ALDH1A1LMNASMN1; SMN2CXCR5APLNR
SCHEMBL26341725 0.76 LMNA (0.67) ALDH1A1LMNASMN1; SMN2CXCR5APLNR
SCHEMBL5924123 0.76 GRM5 (1.00) ALDH1A1LMNAGRM5MAPT
SCHEMBL26342419 0.76 SMN1; SMN2 (0.62) ALDH1A1LMNASMN1; SMN2CXCR5APLNR
SCHEMBL27171248 0.73 ALDH1A1 (0.68) ALDH1A1LMNASMN1; SMN2CXCR5APLNR
SCHEMBL16112358 0.73 LMNA (0.72) ALDH1A1LMNASMN1; SMN2CXCR5APLNR
SCHEMBL26341663 0.72 LMNA (0.72) ALDH1A1LMNASMN1; SMN2CXCR5APLNR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240083871-A1 DIPHENYLPYRAZOLE COMPOUND, AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF NORTHWEST A&F UNIVERSITY (CN) 2024-03-14 — — US disclosed
EP-4249480-A1 DIPHENYLPYRAZOLE COMPOUND, AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF Northwest A&F University (CN) 2023-09-27 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240083871-A1 DIPHENYLPYRAZOLE COMPOUND, AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF GSTP1, CYP4F11, GSTA1 ALDH1A1 467/4885LMNA 4766/4885SMN1; SMN2 4614/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback